HMOX1 and neoplasm: In a pre-clinical model, we observed that a combination treatment with a c-Met inhibitor and a HO-1 inhibitor ZnPP markedly decreased the growth of renal tumors with reduced blood vessel densities; and it is associated with markedly increased oxidative stress, DNA damage and apoptotic markers within the tumor tissues.